Inner Mongolia Baotou Steel Union Co., Ltd. (600010.SS)
Baotou, CN
Qingdao Haier Biomedical Co., Ltd. specializes in the global development, production, sales, and distribution of low-temperature storage solutions for critical biomedical samples. Their extensive product portfolio includes a range of freezers—such as cryogenic, ultra-low temperature, biomedical, spark-free, vaccine, and plasma models—along with refrigerators designed for laboratories, pharmacies, blood banks, and vaccine storage. They also provide blood/fluid warming cabinets, essential backup systems, consumables, and specialized cold/freezer rooms, alongside comprehensive vaccine safety solutions and plasma apheresis systems. Beyond storage, the company delivers various healthcare innovations, including intelligent mobile inoculation clinics, refrigerated vaccine transport vehicles, advanced vaccine shelters, P2+ mobile nucleic acid testing vehicles, smart autonomous disinfection units, and air purification sterilizers. Their offerings further extend to medical diagnostic and support tools like infrared thermometers, blood pressure monitors, and oxygen concentrators, as well as biosafety screening booths, solar-powered medical laboratories, mobile PCR testing labs, and versatile mobile container clinics. Complementing these, they supply a selection of general laboratory equipment and transport coolers. Established in 2005, Qingdao Haier Biomedical Co., Ltd. is headquartered in Qingdao, China. Separately, Inner Mongolia Baotou Steel Union Co., Ltd. operates as a subsidiary of Baotou Iron and Steel (Group) Co., Ltd.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.44% | +0.00% | -0.71% | +4.85% | +8.08% | +18.07% | +55.25% | +53.55% | +51.89% | +37.75% | +185.22% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Steel: +1.2%-2.7% Q1'26: -13.7% (vs Q1'25)
-
EPS growth Steel: +17.4%+43.1% ★ Q1'26: -1,120.0% (vs Q1'25)
-
FCF margin FCF growth · Steel: +44.2%-2.3% Q1'26: -20.7% (vs Q1'25)
-
EBIT margin Steel: +5.8%+3.2% Q1'26: -1.4% (vs Q1'25)
-
ROIC Steel: +4.3%+1.5% Q1'26: -0.8% (vs Q1'25)
-
Share dilution Steel: +0.0%-1.3% ★ Q1'26: +0.9% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Steel: 0.57×8.68× Q1'26: -48.10× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
22.50B
est: 29.79B (-24.5%)
|
31.03B
est: 29.79B (+4.2%)
|
53.68B
est: 26.62B (+101.7%)
|
67.19B
est: 30.43B (+120.8%)
|
63.40B
est: 33.50B (+89.3%)
|
59.27B
est: 59.04B (+0.4%)
|
86.18B
est: 86.06B (+0.1%)
|
72.17B
est: 84.91B (-15.0%)
|
70.57B
est: 66.26B (+6.5%)
|
68.09B
est: 71.73B (-5.1%)
|
66.23B
est: 70.67B (-6.3%)
|
72.54B
72.54B – 72.54B
+2.6% YoY
|
74.34B
74.34B – 74.34B
+2.5% YoY
|
| EBITDA |
-2.22B
est: 2.76B (-180.5%)
|
3.78B
est: 2.76B (+37.0%)
|
8.06B
est: 2.47B (+227.1%)
|
9.38B
est: 2.82B (+232.8%)
|
7.05B
est: 3.10B (+127.4%)
|
6.94B
est: 5.47B (+27.0%)
|
9.23B
est: 7.97B (+15.8%)
|
4.35B
est: 7.86B (-44.7%)
|
6.31B
est: 6.14B (+2.8%)
|
6.07B
est: 8.79B (-30.9%)
|
7.15B
est: 8.66B (-17.5%)
|
8.89B
8.89B – 8.89B
+2.6% YoY
|
9.11B
9.11B – 9.11B
+2.5% YoY
|
| EBIT |
-5.18B
est: 1.15B (-550.5%)
|
289.52M
est: 1.15B (-74.8%)
|
4.68B
est: 1.03B (+355.0%)
|
6.31B
est: 1.18B (+437.0%)
|
3.61B
est: 1.29B (+179.1%)
|
3.16B
est: 2.28B (+38.5%)
|
5.81B
est: 3.32B (+74.9%)
|
895.55M
est: 3.28B (-72.7%)
|
2.35B
est: 2.56B (-8.3%)
|
1.82B
est: 2.47B (-26.4%)
|
2.13B
est: 2.43B (-12.5%)
|
2.49B
2.49B – 2.49B
+2.6% YoY
|
2.56B
2.56B – 2.56B
+2.5% YoY
|
| Net Income |
-3.31B
|
85.03M
est: -1.30B (+106.5%)
|
2.06B
est: -1.30B (+258.1%)
|
3.32B
est: -651.81M (+609.9%)
|
667.93M
est: 1.63B (-59.0%)
|
405.96M
est: 456.26M (-11.0%)
|
2.87B
est: 3.19B (-10.2%)
|
-726.39M
est: -684.39M (-6.1%)
|
515.27M
est: 456.26M (+12.9%)
|
264.63M
est: 450.15M (-41.2%)
|
373.62M
est: 900.30M (-58.5%)
|
900.30M
900.30M – 900.30M
+0.0% YoY
|
900.30M
900.30M – 900.30M
+0.0% YoY
|
| SGA |
938.10M
est: 365.86M (+156.4%)
|
1.69B
est: 365.86M (+362.9%)
|
2.38B
est: 326.92M (+627.8%)
|
2.60B
est: 373.71M (+596.3%)
|
2.81B
est: 411.38M (+582.8%)
|
953.73M
est: 725.04M (+31.5%)
|
851.18M
est: 1.06B (-19.5%)
|
1.20B
est: 1.04B (+15.1%)
|
688.70M
est: 813.74M (-15.4%)
|
616.01M
est: 990.74M (-37.8%)
|
1.57B
est: 976.07M (+61.1%)
|
1.00B
1.00B – 1.00B
+2.6% YoY
|
1.03B
1.03B – 1.03B
+2.5% YoY
|
| EPS |
-0.09
|
0.00
est: -0.03 (+106.7%)
|
0.05
est: -0.03 (+258.2%)
|
0.07
est: -0.01 (+611.0%)
|
0.02
est: 0.04 (-45.1%)
|
0.01
est: 0.01 (+45.0%)
|
0.06
est: 0.07 (-10.1%)
|
-0.03
est: -0.02 (-111.3%)
|
0.01
est: 0.01 (+13.0%)
|
0.01
est: 0.01 (-42.0%)
|
0.01
est: 0.02 (-58.5%)
|
0.02
0.02 – 0.02
+0.0% YoY
|
0.02
0.02 – 0.02
+0.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-08 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-07 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-06 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-30 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-29 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-28 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-27 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-24 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-23 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-22 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-21 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-20 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-17 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-16 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | HSBC MSCI China A UCITS ETF HMCT.L | 0.21% | 278.9K | 0.30% |
| 2 | Amundi MSCI China A UCITS ETF Acc CNAA.L | 0.20% | 287.1K | 0.35% |
| 3 | iShares MSCI China A ETF CNYA | 0.19% | 453.5K | 0.60% |
| 4 | Xtrackers Harvest CSI 300 China A-Shares ETF ASHR | 0.19% | 2.62M | 0.65% |
| 5 | iShares MSCI China A UCITS ETF CNYE.MI | 0.19% | 194.8K | 0.45% |
| 6 | iShares MSCI China A UCITS ETF CNYA.L | 0.19% | 5.91M | 0.40% |
| 7 | Xtrackers Harvest CSI300 UCITS ETF 1D ASHR.L | 0.19% | 595.5K | 0.65% |
| 8 | Xtrackers MSCI China A UCITS ETF 1C XX2D.L | 0.19% | 258.9K | 0.35% |
| 9 | Samsung KODEX China CSI300 ETF 283580.KS | 0.17% | 346.9K | 0.12% |
| 10 | Xtrackers Harvest CSI A500 UCITS ETF 1D AH50.L | 0.16% | 26.7K | 0.65% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Mi Liu | Chief Financial Officer, Head of Accounting, Company Secretary & Director | — | female |
| Wei Guo | Deputy General Manager | — | male |
| Xin Ni | Deputy General Manager | — | male |
| Yabin Huang | Deputy General Manager | — | male |
| Zhao Zhang | Chairman & Legal Representative | — | male |
| Zhi Gang Liang | GM & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 600010.SS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
